Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe

被引:60
作者
Li, XD
Pan, WS
Nie, SF
Wu, LJ
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmaceut, Sch Pharm, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Coll Tradit Chinese Med, Shenyang, Peoples R China
关键词
effervescent osmotic pump tablet; Traditional Chinese Medicine Compound Recipe; controlled release; release theory; in-vitro-in-vivo correlation;
D O I
10.1016/j.jconrel.2004.01.026
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
A controlled release effervescent osmotic pump tablet (EOPT) of Traditional Chinese Medicine Compound Recipe (TCMCR), named Fuzilizhong prescription which includes acidic drugs consisted of many known and unknown effective components and has been used for several thousands years, was successfully prepared with sodium chloride, sodium hydrogen carbonate and hydroxypropylmethylcellulose(HPMC) as osmotic agents. Since the osmotic pressure in EOPT with sodium chloride and sodium hydrogen carbonate increased greatly, which was induced mostly by gas carbon dioxide generating from the reaction of sodium hydrogen carbonate and the acidic drugs in TCMCR after the fluid being imbibed into the compartment through the semipermeable membrane and the in vitro accumulative dissolution percent from prescription 3 was up to 96.6% at 14 hour, the problem that water insoluble drugs can not to be elementary osmotic pump tablet for its low dissolution rate was solved in the paper. On the basis of prescription 3, the drug in effervescent osmotic pump tablet was released controllably after HPMC was selected as retarder and has a good in-vitro-in-vivo correlation(IVIVC, r=0.9550). Threrfore, it could be concluded that the formulation of TCMCR is appropriate to being made into EOPT, which improves acidic drugs composed of soluble and poorly soluble components release more greatly and controllably. From the point of this, water insoluble drugs can be designed to elementary osmotic pump tablet for more complete dissolution release. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 15 条
[1]
BAI J, 1989, AGEDNESS ANTICADUCIT, P152
[2]
CAO C, 1993, COMMENTS TRADITIONAL, P163
[3]
CHEN Q, 1998, PHARMACOLOGY CLIN FA, P312
[4]
ASYMMETRIC-MEMBRANE TABLET COATINGS FOR OSMOTIC DRUG-DELIVERY [J].
HERBIG, SM ;
CARDINAL, JR ;
KORSMEYER, RW ;
SMITH, KL .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) :127-136
[5]
LI Z, 2001, MODERN GERIATRIC PHA, P7
[6]
Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent [J].
Okimoto, K ;
Rajewski, RA ;
Stella, VJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (01) :29-38
[7]
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent [J].
Okimoto, K ;
Ohike, A ;
Ibuki, R ;
Aoki, O ;
Ohnishi, N ;
Rajewski, RA ;
Stella, VJ ;
Irie, T ;
Uekama, K .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :311-319
[8]
PAN W, 2000, J SHENYANG PHARM U, V17, P147
[9]
Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems [J].
Shin, SC ;
Lee, HJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :201-206
[10]
Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets [J].
Takka, S ;
Sakr, A ;
Goldberg, A .
JOURNAL OF CONTROLLED RELEASE, 2003, 88 (01) :147-157